Taming TRAIL: the winding path to a novel form of cancer therapy

This publication has 6 references indexed in Scilit:

• Histone deacetylase inhibitors interact synergistically with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in carcinoma cell lines
  Investigational New Drugs, 2005
• Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells
  Oncogene, 2004
• Increased Susceptibility to Tumor Initiation and Metastasis in TNF-Related Apoptosis-Inducing Ligand-Deficient Mice
  The Journal of Immunology, 2002
• Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL)
  The Lancet, 2000
• Lethal effect of the anti-Fas antibody in mice
  Nature, 1993
• Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis
  Science, 1989